期刊文献+

丙型肝炎病毒核心抗原在静脉吸毒者血清中的检测 被引量:2

Detection of hepatitis C core antigen in intravenous drug addictions
原文传递
导出
摘要 目的 调查丙型肝炎病毒核心抗原(HCVcAg)在静脉吸毒者血清中的检出状况。方法 对93例静脉吸毒者血清同时进行HCVcAg、HCV RNA定量、抗HCV IgG、HBsAg检测,分析HCVcAg检出率与HCV RNA定量及合并HBV感染之间的关系。结果 在93例静脉吸毒者中,抗HCV IgG阳性79例,HCV RNA阳性68例,HCVcAg阳性37例。以HCV RNA作比较,HCVcAg检测的特异性和敏感性分别是100%和54%;HCVcAg检出率与HCV RNA载量对数值呈正相关,r=0.958,P=0.010;HCV RNA阳性静脉吸毒者中,HBsAg阳性和HBsAg阴性时HCVcAg的检出率分别为38%和69%,两者比较P<0.01;2例抗HCV IgG阴性、HCV RNA阳性静脉吸毒者,HCVcAg检测呈阳性。结论 HCVcAg在静脉吸毒者血清中检测其特异性好,而敏感性较差;HCVcAg的检出率与HCV RNA载量的对数呈正相关;在静脉吸毒者,合并HBV感染可能是血清HCVcAg检测的干扰因素,可能是HBV抑制了HCVcAg的表达。 Objective To study the status of detection of hepatitis C core antigen in intravenous drug addictions, and discuss the foreground of the hepatitis C core antigen ELISA test system. Methods HCV core antigen, HCV RNA quantity, anti HCV-IgG, HBsAg were analysis in all the plasma samples taken from 93 cases of intravenous drug users. Results The specialty and sensitivity of HCV core antigen in intravenous drug addictions 100%-54% separately. When HBsAg were positive, the sensitivity of HCV core antigen was 38% , while HBsAg negative, the sensitivity of HCV core antigen was 69% ( P 〈 0. 01 ).Conclusion The detections of HCV core antigen showed high specialty but low sensitivity in intravenous drug addictions. The positive rate has positive relation with HCV RNA virus logarithm quantity. Coinfection with HBV are the interfere factor of HCV core antigen detection. In screening experimentations, the detection of HCV core antigen in plasma may be applied as supplement method for anti-HCV-IgG. It can also be used to monitor viremia in HCV infection.
出处 《中华实验和临床病毒学杂志》 CAS CSCD 北大核心 2011年第4期304-306,共3页 Chinese Journal of Experimental and Clinical Virology
关键词 肝炎病毒 肝炎核心抗原 丙型 物质滥用 静脉内 Hepacivirus Hepatitis C core antigens Substance abuse, intravenous
  • 相关文献

参考文献6

  • 1Leie PN, Cuypers HT, Reesink HW, et al. Patterns of serological markers in transfusion-transmitted hepatitis C virus infection using second-generation HCV assays. J Med Virol,1992,37:203-209.
  • 2Schrelber GB, Busch MP, Kleshiwakuma SH, et al.Performance of an enzyolinked immunosorbent assay system for antibodies to hepatitis C virus with two antigens(c11/c7).Clin Chem,1992,38:2434-2439.
  • 3Busch MP,Korelitz JJ,Kleinmen SH,et al.Declining value of alanine aminotranferase in screening of blood donors to prevent posttransfusion hepatitis B and C virus infection.The Retrovirus Epidemiology Donor Study.Transfusion,1995,35:903-910.
  • 4Ohno T,Lau JYN.The “ gold-standard”,accuracy,and the current concepts:hepatitis C virus genotype and viremia.Hepatology,1996,19:1312.
  • 5吴荣辉.丙型肝炎病毒核心抗原在血液透析患者中的检测和应用[J].中华实验和临床病毒学杂志,2009,23(3):232-234. 被引量:2
  • 6王福成,施之雍,蔡隽,苏俊.丙型肝炎病毒核心抗原检测用于献血者筛查价值的探讨[J].中华实验和临床病毒学杂志,2007,21(4):389-390. 被引量:8

二级参考文献14

  • 1王国华,张贺秋,李少波,刘劭钢,陈坤,宋晓国,凌世淦.丙型肝炎病毒核心抗原检测试剂的研制及初步应用[J].中国输血杂志,2004,17(5):299-301. 被引量:37
  • 2Petrosillo N,Gilli P,Serraina D,et al.Prevalence of iffected patients and understaffing have a role in hepatitis C virus transmission in dialysis.Am J Kidney Dis,2001,37:1004-1010.
  • 3Weiss J,Wu J,Fsrrenkopf B,et al.Real time Taq Man PCR detec2tion and quantitation of HBV genotype A2G with the use of an inter2nal quantition standard.J Clin Virol,2004,30:86.
  • 4Simmonds P.Virology of hepatitis C virus.Clin Therapeutics,1996,18(Supplement2):9.
  • 5Selda E.Diagnosis of hepatitis C virus (uev) infection andlaboratory monitoring of its therapy.J clin virol,2001,21:271.
  • 6Scbreher GB,Bush MP,Kleinman SH,et al.The risk of transfu2sion2transmitted viral infections epidemiology donor study.NEng J Med,1996,334:1685.
  • 7孟淑芳 李秀华 尹红章 李德富.血浆或血清样本中丙型肝炎病毒抗原的检测[J].中华微生物学和免疫学杂志,1999,19:80-80.
  • 8Peterson J, Gteen G, Lida K, et al. Detection of hepatitis C core antigen in the antibody negative " window" phase of hepatitis C infection. Vox Sang, 2000,78 : 80-85.
  • 9Lee SR, Pctcrson J, Nivcn P, ct al. Efficacy of a hepatitis C virus core antigen enzyme-linked immunosorbent assay for the identification of "window-phase" blood donations. Vox Sang,2001,80:19-23.
  • 10Courouce AM, Marrec NL, Bouchardeau F, et al. Efficacy of HCV core antigen detection during the preset seroconvcrsion period. Transfusion, 2000,40:1198-1202.

共引文献8

同被引文献17

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部